NHS Trusts Move to iSOFT's Pathology Tool to Boost Performance

iSOFTTwo NHS trusts have switched to iSOFT's CorVu laboratory management reporting tool to boost performance in pathology, amid pressure on the NHS to increase efficiency and cut costs.

North Cumbria University Hospitals NHS Trust will use CorVu to analyse department statistics to improve the turnaround times of pathology tests at the Cumberland Infirmary in Carlisle and nearby West Cumberland Hospital at Whitehaven. The order follows a recent upgrade of iSOFT's laboratory information system, i.Laboratory.

At St George's Healthcare NHS Trust meanwhile, CorVu is replacing a management reporting system that is unable to keep pace with the demands on modern pathology services. Its 180 pathology staff deal with 697,000 orders and 7.5 million pathology tests a year.

"Being able to view workloads in real time will enable us to closely match resources and respond at once to pressures and changing priorities," said the trust's project manager, Andrew Stewart. "With CorVu, we can view departmental data in greater depth to expose problem areas and so increase throughput and improve quality."

The move to CorVu is part of an overhaul of laboratory systems at the 1,000-bed St George's Hospital in Tooting, south London, and coincides with a new five-year deal. The contract extension includes an upgrade to iSOFT's latest i.Laboratory solution and new hardware.

St George's Healthcare has used i.Laboratory since 1994 and partnered on several key developments, including a blood transfusion module, and will again collaborate to further develop the CorVu product.

"The integration of the CorVu application is part of our customer promise to deliver innovative solutions that improve performance and deliver genuine business benefits," said Adrian Stevens, Managing Director of iSOFT's UK and Ireland business. "As the UK's largest provider of laboratory information systems, we have a responsibility to constantly innovate to help our customers meet ever-demanding efficiency, quality and cost targets."

The introduction of CorVu in the UK follows an agreement with its US-based developers, Rocket Software.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organizations.

Today, more than 13,000 provider organizations in over 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 3,300 specialists in 19 countries worldwide.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...